Explores biomarkers and interventions targeting the gut-brain axis to improve outcomes in Parkinson's Disease, suggesting new strategies for care.
Advancing knowledge of the gut-brain axis in PD presents valuable opportunities for early biomarkers and microbiota-targeted interventions, offering novel strategies to delay disease progression and improve patient quality of life.
No takes yet. Share an insight, caveat, or question.
Saini et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: